NEUROCRINE BIOSCIENCES INC·4

Feb 17, 5:47 PM ET

Onyia Jude 4

Research Summary

AI-generated summary

Updated

Neurocrine (NBIX) CSO Onyia Jude Exercises Options & Receives Award

What Happened

  • Onyia Jude, Chief Scientific Officer of Neurocrine Biosciences (NBIX), exercised/converted derivative awards and received vested RSUs/PRSUs in transactions on Feb 12–13, 2026. The filing shows gross issuances/ conversions totaling 92,690 shares. The company withheld 15,099 shares to satisfy tax withholding obligations (payment value shown as $1,872,634), leaving a net of about 77,591 shares issued to Jude.
  • Specific cash/tax-withholding entries reported: 1,426 shares withheld at $123.10 (=$175,541); 1,452 shares withheld at $124.12 (=$180,222); 1,466 shares withheld at $124.12 (=$181,960); and 10,755 shares withheld at $124.12 (=$1,334,911). Several 0.00-priced entries reflect exercises/conversions or the vesting/grant of RSUs/PRSUs rather than open-market sales.

Key Details

  • Transaction dates: Feb 12–13, 2026; Form 4 filed Feb 17, 2026 (reporting period begins Feb 12, 2026).
  • Gross shares issued/converted: 92,690; shares withheld for taxes: 15,099 (value $1,872,634); net shares received ≈ 77,591.
  • Transaction types: M = exercised/converted derivatives; A = grant/award (RSU/PRSU); F = shares withheld to satisfy tax withholding (company withholding, not open‑market sales).
  • Notable footnotes:
    • F1: Shares withheld by the company to satisfy tax withholding; no open-market sale.
    • F2: PRSUs granted May 19, 2023 vested at 125% of target after certification on Feb 13, 2026.
    • F4–F6/F8: Describe timing and schedules of RSU grants and vesting.
  • Shares owned after the transaction: not specified in the provided filing summary.

Context

  • This is primarily a compensation/vesting event (exercises and RSU/PRSU vesting) with tax-withholding handled by share retention — a routine occurrence for executives, not an open‑market sale.
  • Withheld-share tax payments are different from selling shares in the market; they do not necessarily indicate a decision to realize cash proceeds by the insider.
  • For retail investors: vesting/exercise events increase the insider’s reported holdings (net of withheld shares) but are standard compensation mechanics; purchases would be a more explicit bullish signal, while withholding for taxes is routine.